kevin niswender Archives
Jul. 12, 2018—A drug used to treat diabetes, liraglutide, may point to new therapies for respiratory syncytial virus (RSV) bronchiolitis — inflammation and obstruction of the lungs’ small airways.
Nov. 30, 2017—Kevin Niswender, MD, PhD, whose work has helped advance understanding of the neural underpinnings of obesity and metabolic syndrome, has been named director of the Clinical Research Center (CRC) at Vanderbilt University Medical Center (VUMC).
Mar. 16, 2017—Vanderbilt University Medical Center (VUMC) is one of four centers receiving a $15 million, four-year research award from the American Heart Association (AHA) to provide cutting-edge research on obesity as part of its sixth Strategically Focused Research Network (SFRN).
Jan. 19, 2017—Investigators in the Division of Allergy, Pulmonary, and Critical Care Medicine and the Division of Diabetes, Endocrinology, and Metabolism recently received a $1.25 million grant from the National Institute of Allergy and Infectious Diseases.
Jan. 29, 2016—In the latest VUCast: Learn about a breakthrough breast cancer test that determines which chemo works best on a tumor; see how obese children's brains are different than those of their healthy-weight peers; and find out how "sticky mittens" could help babies later in life.
Jan. 28, 2016—Kevin Niswender, M.D., Ph.D., a physician-scientist at Vanderbilt University Medical Center whose work has helped advance understanding of diseases ranging from obesity to schizophrenia, is one of 10 recipients of the 2016 Harrington Scholar-Innovator Awards.
Jan. 21, 2016—The brains of children who are obese function differently from those of children of healthy weight, and exhibit an “imbalance” between food-seeking and food-avoiding behaviors, researchers at Vanderbilt University Medical Center have found.
Sep. 24, 2015—Disruptions in a specific signaling pathway in the brain can cause overeating of high-fat food, researchers at Vanderbilt University have found.
Nov. 18, 2014—Vanderbilt researchers will play a key role in the second phase of the federal "tissue chip for drug screening" program.
Jun. 2, 2014—An international research group led by Vanderbilt University scientists has shown for the first time that a lipid, or fat molecule, can regulate “psychostimulant” behaviors by interacting with a brain protein.